• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Feb;27(2):666-669.
doi: 10.3201/2702.204480.
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020

Sitanshu Sekhar Kar, Sonali Sarkar, Sharan Murali, Rahul Dhodapkar, Noyal Mariya Joseph, Rakesh Aggarwal

Abstract

We conducted 3 population-based cross-sectional surveys, at 1-month intervals, to estimate the prevalence and time-trend of severe acute respiratory syndrome coronavirus 2 infection in Puducherry, India. Seropositivity rate increased from 4.9% to 34.5% over 2 months and was 20-fold higher than the number of diagnosed cases of infection.

Keywords: COVID-19; India; Puducherry; SARS; SARS-CoV-2; coronavirus disease; epidemiology; respiratory infections; seroepidemiologic study; severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom